famirial short stature, idopathic short stature, Noonan syndrome, and good/poor respoders of growth hormone therapy
Conditions
Interventions
None listed
Sponsors
Keio University, School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients of growth impairment 1) who are informed that he or she might have agenetic disease, 2) who can see the pediatric endocrinologist and can
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gene analysis and functional assay | — |
Countries
Japan
Contacts
Public ContactTomonobu Hasegawa
Keio University, School of Medicine Department of Pediatrics
Outcome results
None listed